Parkinsonism occurring during methyldopa therapy.
作者信息
Strang R R
出版信息
Can Med Assoc J. 1966 Oct 29;95(18):928-9.
Abstract
摘要
相似文献
1
Parkinsonism occurring during methyldopa therapy.甲基多巴治疗期间发生的帕金森综合征。
Can Med Assoc J. 1966 Oct 29;95(18):928-9.
2
[Methyldopa and parkinsonism].[甲基多巴与帕金森病]
Ugeskr Laeger. 1973 Mar 26;135(13):714-5.
3
Exacerbation of parkinsonism by methyldopa.甲基多巴所致帕金森综合征加重
JAMA. 1980 Dec 19;244(24):2727-8. doi: 10.1001/jama.1980.03310240019007.
4
Parkinsonism induced by methyldopa.甲基多巴诱发的帕金森综合征。
S Afr Med J. 1984 Feb 11;65(6):194.
5
Galactorrhea and Parkinson-like syndrome: an adverse effect of alpha-methyldopa.溢乳和帕金森样综合征：α-甲基多巴的一种不良反应。
Metabolism. 1970 Dec;19(12):1068-70. doi: 10.1016/0026-0495(70)90031-4.
6
Relationship between Meige syndrome and alpha-methyldopa-induced parkinsonism.Meige综合征与α-甲基多巴诱发的帕金森综合征之间的关系。
Neurology. 1985 Nov;35(11):1668-9. doi: 10.1212/wnl.35.11.1668.
7
[Parkinson disease induced by flunarizine].
Arq Neuropsiquiatr. 1989 Dec;47(4):471-3.
8
Prolonged diarrhea secondary to methyldopa therapy.甲基多巴治疗继发的长期腹泻。
Drug Intell Clin Pharm. 1983 Jun;17(6):462.
9
Long-term treatment of hypertension with methyldopa. VIII. Overview.甲基多巴对高血压的长期治疗。VIII. 概述。
J Cardiovasc Pharmacol. 1981;3 Suppl 2:S120-7.
10
Long-term treatment of hypertension with methyldopa. IV. Duration of methyldopa therapy.甲基多巴对高血压的长期治疗。IV. 甲基多巴治疗的持续时间。
J Cardiovasc Pharmacol. 1981;3 Suppl 2:S99-103.
引用本文的文献
1
Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.抗帕金森病药物：临床显著的药物相互作用和不良反应及其管理。
CNS Drugs. 1998 Apr;9(4):291-310. doi: 10.2165/00023210-199809040-00005.
2
Parkinson's disease between internal medicine and neurology.内科与神经科之间的帕金森病。
J Neural Transm (Vienna). 2016 Jan;123(1):3-17. doi: 10.1007/s00702-015-1443-z. Epub 2015 Aug 23.
3
Diagnosis and treatment of Parkinson's disease in the elderly.老年帕金森病的诊断与治疗
J Gen Intern Med. 1994 Oct;9(10):583-9. doi: 10.1007/BF02599289.
4
[The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. II. Alterations of cerebrospinal fluid in patients with Parkinson's disease and chorea following the administration of alpha-methyldopa].
Dtsch Z Nervenheilkd. 1969;196(3):256-65.
5
[Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].帕金森病的鉴别治疗，特别提及医源性疾病的可能性（作者译）
Arch Psychiatr Nervenkr (1970). 1974 Apr 9;218(4):319-38. doi: 10.1007/BF00342576.
本文引用的文献
1
METHYLDOPA AND PARKINSONISM.甲基多巴与帕金森病
Br Med J. 1964 Sep 12;2(5410):687. doi: 10.1136/bmj.2.5410.687-a.
2
PARKINSONISM ASSOCIATED WITH ALPHA-METHYLDOPA THERAPY.与α-甲基多巴治疗相关的帕金森综合征
Br Med J. 1964 Jul 18;2(5402):168. doi: 10.1136/bmj.2.5402.168.
3
ADMINISTRATION OF DIHYDROXYPHENYLALANINE TO PARKINSONIAN PATIENTS.
Can Med Assoc J. 1964 Feb 15;90(7):463-6.
4
The pathogenesis of Parkinson's disease: a new hypothesis.帕金森病的发病机制：一种新假说。
Can Med Assoc J. 1962 Oct 13;87(15):802-7.
5
6
Parkinsonism occurring with methyldopa treatment.甲基多巴治疗引发的帕金森综合征。
Br Med J. 1963 Apr 13;1(5336):1001. doi: 10.1136/bmj.1.5336.1001.
7
Dopamine metabolism in Parkinson's disease.帕金森病中的多巴胺代谢
Neurology. 1963 Jan;13:73-6. doi: 10.1212/wnl.13.1.73.
8
[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].[左旋多巴（L-3,4-二羟基苯丙氨酸）对帕金森氏症运动不能的作用]
Wien Klin Wochenschr. 1961 Nov 10;73:787-8.
Zotero 插件